Abstract
Curcumin (diferuloylmethane) is a yellow polyphenol found in the rhizome of the annual herb turmeric (Curcuma longa) belonging to the family Zingiberaceae. Its interaction with a huge number of molecular targets like cytokines, growth factors, transcription factors, receptors, pro-inflammatory enzymes, protein kinases and adhesion molecules has been studied extensively. Interaction of curcumin with nucleic acids has been the focus of extensive research in recent years. Curcumin is observed to be genotoxic and antigenotoxic agent in time and concentration dependent manner. Curcumin and its derivatives either alone or as metal complexes have been reported to bind directly to DNA. The interactions are mainly as DNA minor groove binding or as DNA intercalating agents. The similarity in the shape of curcumin to DNA minor groove binding drugs is the motivation for exploring its binding to DNA minor grooves. Thus curcumin is a “double edged sword”: having therapeutic potential as a minor groove binder but at the same time it may cause DNA damage in the cell at high concentration. The purpose of this review is to summarize the current information related to interaction of curcumin metal complexes and its derivatives with nucleic acids and the implication such interaction can have on therapeutics.
Keywords: Curcumin metal complex, Genotoxic and antigenotoxic agent, Reactive oxygen species (ROS), DNA damage, DNA minor groove binding, DNA intercalation
Mini-Reviews in Medicinal Chemistry
Title:Interactions of Curcumin and Its Derivatives with Nucleic Acids and their Implications
Volume: 13 Issue: 2
Author(s): Anil Kumar and Utpal Bora
Affiliation:
Keywords: Curcumin metal complex, Genotoxic and antigenotoxic agent, Reactive oxygen species (ROS), DNA damage, DNA minor groove binding, DNA intercalation
Abstract: Curcumin (diferuloylmethane) is a yellow polyphenol found in the rhizome of the annual herb turmeric (Curcuma longa) belonging to the family Zingiberaceae. Its interaction with a huge number of molecular targets like cytokines, growth factors, transcription factors, receptors, pro-inflammatory enzymes, protein kinases and adhesion molecules has been studied extensively. Interaction of curcumin with nucleic acids has been the focus of extensive research in recent years. Curcumin is observed to be genotoxic and antigenotoxic agent in time and concentration dependent manner. Curcumin and its derivatives either alone or as metal complexes have been reported to bind directly to DNA. The interactions are mainly as DNA minor groove binding or as DNA intercalating agents. The similarity in the shape of curcumin to DNA minor groove binding drugs is the motivation for exploring its binding to DNA minor grooves. Thus curcumin is a “double edged sword”: having therapeutic potential as a minor groove binder but at the same time it may cause DNA damage in the cell at high concentration. The purpose of this review is to summarize the current information related to interaction of curcumin metal complexes and its derivatives with nucleic acids and the implication such interaction can have on therapeutics.
Export Options
About this article
Cite this article as:
Kumar Anil and Bora Utpal, Interactions of Curcumin and Its Derivatives with Nucleic Acids and their Implications, Mini-Reviews in Medicinal Chemistry 2013; 13 (2) . https://dx.doi.org/10.2174/1389557511313020007
DOI https://dx.doi.org/10.2174/1389557511313020007 |
Print ISSN 1389-5575 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5607 |
Call for Papers in Thematic Issues
Bioprospecting of Natural Products as Sources of New Multitarget Therapies
According to the Convention on Biological Diversity, bioprospecting is the exploration of biodiversity and indigenous knowledge to develop commercially valuable products for pharmaceutical and other applications. Bioprospecting involves searching for useful organic compounds in plants, fungi, marine organisms, and microorganisms. Natural products traditionally constituted the primary source of more than ...read more
Computational Frontiers in Medicinal Chemistry
The thematic issue "Computational Frontiers in Medicinal Chemistry" provides a robust platform for delving into state-of-the-art computational methodologies and technologies that significantly propel advancements in medicinal chemistry. This edition seeks to amalgamate top-tier reviews spotlighting the latest trends and breakthroughs in the fusion of computational approaches, including artificial intelligence (AI) ...read more
Drugs and mitochondria
Mitochondria play a central role in the life and death of cells. They are not merely the center for energy metabolism but are also the headquarters for different catabolic and anabolic processes, calcium fluxes, and various signaling pathways. Mitochondria maintain homeostasis in the cell by interacting with reactive oxygen-nitrogen species ...read more
Mitochondria as a Therapeutic Target in Metabolic Disorders
Mitochondria are the primary site of adenosine triphosphate (ATP) production in mammalian cells. Moreover, these organelles are an important source of reactive oxygen and nitrogen species in virtually any nucleated cell type. The modulation of a myriad of cellular signaling pathways depends on the mitochondrial physiology. Mitochondrial dysfunction is observed ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pleiotropic Effects of Cathepsin D
Endocrine, Metabolic & Immune Disorders - Drug Targets Stimuli-Responsive Nanoparticles for siRNA Delivery
Current Pharmaceutical Design Processing of Amyloid Precursor Protein and Amyloid Peptide Neurotoxicity
Current Alzheimer Research Liposomal-All-trans-Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
Current Cancer Therapy Reviews Neuroprotective Properties of Antiepileptics: What are the Implications for Psychiatric Disorders?
Current Medicinal Chemistry Guggulsterone for Chemoprevention of Cancer
Current Pharmaceutical Design Beyond Estrogen: Targeting Gonadotropin Hormones in the Treatment of Alzheimers Disease
Current Drug Targets - CNS & Neurological Disorders Antioxidant Activity of Galantamine and Some of its Derivatives
Current Medicinal Chemistry Cancer Nanotheranostics: A Nanomedicinal Approach for Cancer Therapy and Diagnosis
Anti-Cancer Agents in Medicinal Chemistry Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms
Current Topics in Medicinal Chemistry Establishment of Cholinergic Neuron-like Cell Lines with Differential Vulnerability to Nitrosative Stress
Current Neurovascular Research DNA Double Strand Breaks Repair Inhibitors: Relevance as Potential New Anticancer Therapeutics
Current Medicinal Chemistry Pleiotropic Effects of Cardioactive Glycosides
Current Medicinal Chemistry The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma
Anti-Cancer Agents in Medicinal Chemistry Regulation of Bcl-2 Family Proteins by Posttranslational Modifications
Current Molecular Medicine Monoclonal Antibodies, Small Molecule Inhibitors and Antibody-drug Conjugates as HER2 Inhibitors
Current Medicinal Chemistry Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Advances in Characterization of Neuroprotective Peptide, Humanin
Current Medicinal Chemistry Targeting Beta-Amyloid Pathogenesis Through Acetylcholinesterase Inhibitors
Current Pharmaceutical Design NK-1 Receptor Antagonists: A New Generation of Anticancer Drugs
Mini-Reviews in Medicinal Chemistry